Fresenius Glycopyrrolate 0,2 mg/1 ml/0,4 mg/2 ml Injection

    Fresenius Glycopyrrolate 0,2 mg/1 ml/0,4 mg/2 ml Injection

    S2


    WHAT FRESENIUS GLYCOPYRROLATE INJECTION IS USED FOR

    Fresenius Glycopyrrolate Injection is used during surgery to decrease secretions such as saliva and during anaesthesia to keep the heart rate normal.

    BEFORE YOU ARE ADMINISTERED FRESENIUS GLYCOPYRROLATE INJECTION

    Fresenius Glycopyrrolate Injection should not be administered to you:

    • if you are hypersensitive to glycopyrrolate or to any of the ingredients of Fresenius Glycopyrrolate Injection
    • if you have an enlarged prostate
    • if you have intestinal blockage

    Special care should be taken with Fresenius Glycopyrrolate Injection:

    • if you have glaucoma (increased pressure in the eye) or asthma
    • in children and elderly patients
    • if you have ulcerative colitis (an inflammatory disease affecting the lining of the colon and rectum) or diarrhoea
    • if you have myasthenia gravis (a neuromuscular disorder manifested as ptosis (drooping eyelids), diplopia (double vision), weakness in arms, hands, fingers, legs and neck, change in facial expression, dysphagia (difficulty swallowing), shortness of breath and dysarthria (impaired speech))
    • if you have fever
    • if you have a high heart rate, high blood pressure and other serious heart conditions.

    Pregnancy and breastfeeding

    If you are pregnant or breastfeeding your baby please consult your doctor, pharmacist or other healthcare professional for advice before receiving Fresenius Glycopyrrolate Injection. You should not receive Fresenius Glycopyrrolate Injection if you are pregnant or breastfeeding your baby. The safety of Fresenius Glycopyrrolate Injection has not been established.

    HOW FRESENIUS GLYCOPYRROLATE INJECTION WILL BE ADMINISTERED

    You will not be expected to give yourself Fresenius Glycopyrrolate Injection. It will be given to you by a person who is qualified to do so. The dosage, method and route of administration, frequency of administration and duration of treatment will be decided by the doctor or healthcare professional based on your condition.

    If you are given more Fresenius Glycopyrrolate Injection than you should:

    Since a healthcare professional will administer Fresenius Glycopyrrolate Injection, he/she will control the dosage. However, in the event of overdosage your doctor will manage the overdosage. In the case of overdose, you may experience increased side effects such as high body temperature, high blood pressure, increased respiration, nausea and vomiting and a rash on the face and upper body. Your doctor may give you appropriate treatment for these side effects.

    POSSIBLE SIDE EFFECTS

    Fresenius Glycopyrrolate Injection can have side effects. Not all side effects reported for Fresenius Glycopyrrolate Injection are included in this leaflet. Should your general health worsen or if you experience any untoward effects while receiving Fresenius Glycopyrrolate Injection, please consult your doctor, pharmacist or other healthcare professional for advice.

    Check with your doctor immediately if any of the following side effects occur:

    • dry mouth with difficulty swallowing and talking
    • thirst
    • decreased bronchial secretions
    • dilation of pupils
    • difficulty in vision
    • sensitivity to light
    • redness and dryness of the skin
    • slow heart rate followed by a rapid heart rate
    • heart beat abnormalities
    • difficulty in passing urine
    • constipation

    Other side effects include:

    • headache
    • nervousness
    • drowsiness
    • weakness
    • dizziness
    • difficulty in falling asleep
    • mental confusion
    • nausea and vomiting
    • difficulty in maintaining an erection
    • difficulty in breastfeeding

    If you notice any side effects not mentioned in this leaflet, please inform your doctor or pharmacist.

    STORING AND DISPOSING OF FRESENIUS GLYCOPYRROLATE INJECTION

    Store all medicines out of reach of children. Store at or below 25 ºC.

    Important Disclaimer

    The Fresenius Glycopyrrolate 0,2 mg/1 ml/0,4 mg/2 ml Injection professional information leaflet below is the property of Fresenius Kabi Manufacturing Sa and is provided on Somayeza exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Somayeza serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>

    Unlock Exclusive Features

    To ensure the fastest, most secure experience, this feature is exclusively available on the free Somayeza mobile app.

    Download the App to Unlock
    On This Page
    Fresenius Glycopyrrolate 0,2 mg/1 ml/0,4 mg/2 ml Injection
    1/-
    Official PDF leaflet

    The patient information text is available above. Load the original PDF only when you need it.

    Somayeza AI
    Hello! I am your medical reading assistant. What would you like to know about this patient information leaflet?
    Successfully Stashed! 💊

    This patient information leaflet has been safely stored in your digital medical cabinet. No prescription needed to view it later!

    View My Favourites